Literature DB >> 15637320

Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke.

Anthony J Furlan1, Marc Fisher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15637320     DOI： 10.1161/01.STR.0000153057.07181.94

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  6 in total

1.  Rapid stent-supported revascularization in acute ischemic stroke.

Authors:  B-F M Fitzsimmons; T Becske; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

Review 2.  The endovascular management of intracranial vascular disease including the MERCI device.

Authors:  Chirag D Gandhi; David M Johnson; Aman B Patel
Journal:  Curr Cardiol Rep       Date:  2007-03       Impact factor: 2.931

Review 3.  Aortic occlusion for cerebral ischemia: from theory to practice.

Authors:  David S Liebeskind
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

Review 4.  Challenges in acute ischemic stroke clinical trials.

Authors:  Anthony J Furlan
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

5.  The endovascular management of intracranial vascular disease including the MERCI device.

Authors:  Chirag D Gandhi; David M Johnson; Aman B Patel
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04

6.  Critical appraisal of medical devices in the management of cerebrovascular disease.

Authors:  Michael J Schneck
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.